These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6191211)

  • 1. Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.
    Waldmeier PC; Baumann PA; Delini-Stula A; Bernasconi R; Sigg K; Buech O; Felner AE
    Mod Probl Pharmacopsychiatry; 1983; 19():31-52. PubMed ID: 6191211
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanol-induced hypothermia and biogenic amine metabolites.
    Alari L; Sjöquist B; Lewander T
    Drug Alcohol Depend; 1987 Jul; 19(4):369-73. PubMed ID: 2440656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
    Sherry RL; Baker GB; Coutts RT
    Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
    [No Abstract]   [Full Text] [Related]  

  • 4. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
    Mefford IN; Roth KA; Jurik SM; Collman V; McIntire S; Tolbert L; Barchas JD
    Brain Res; 1985 Jul; 339(2):342-5. PubMed ID: 2411347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lung, liver and brain monoamine oxidase by imipramine and desipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Mar; 23(6):1138-40. PubMed ID: 4824911
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibition in healthy volunteers by CGP 11305 A, a new specific inhibitor of MAO-A.
    Bieck P; Antonin KH; Jedrychowski M
    Mod Probl Pharmacopsychiatry; 1983; 19():53-62. PubMed ID: 6860425
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for the isolation and determination of 3-methoxytyramine in brain tissue.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):149-58. PubMed ID: 4277335
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent studies with 4-chloramphetamine and some analogues.
    Fuller RW; Molloy BB
    Adv Biochem Psychopharmacol; 1974; 10():195-205. PubMed ID: 4846538
    [No Abstract]   [Full Text] [Related]  

  • 12. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
    Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
    Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocatin-induced inhibition of monoamine oxidase A in rat brain synaptosomes.
    Fernandez-Novoa L; Pastuszko A; Wilson DF
    Biochem Pharmacol; 1991 Nov; 42(12):2351-4. PubMed ID: 1764118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
    Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
    Waldmeier PC; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 19. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
    Waldmeier PC; Baumann PA; Maítre L
    J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the mechanism of action of caroxazone, a new antidepressant drug.
    Moretti A; Caccia C; Calderini G; Menozzi M; Amico A
    Biochem Pharmacol; 1981 Oct; 30(19):2728-31. PubMed ID: 6170295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.